At the news
? NEUTRALIMPACT 2/10 144 filed Sep 14, 2026 at 16:49 ET
Director Berndt Modig filed a Form 144 to sell 2,291 common shares (approx. $87K) on September 14, 2026. The shares were acquired upon vesting of restricted stock units on September 11-12, 2026. This is a small, routine sale by a director to cover tax obligations from RSU vesting, not a discretionary insider sale.
- Director Berndt Modig filed Form 144 to sell 2,291 shares of Pharvaris N.V. common stock.
- Estimated sale value: approximately $87,104 (based on ~$38.02/share).
- Shares were acquired upon vesting of restricted stock units on September 11-12, 2026.
- The sale is part of a pre-arranged 10b5-1 plan, with prior sales in June, July, and August 2026 of similar size.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access